Anti-PLGT2/ KDELC1/ EP58 functional antibody

Anti-PLGT2/ KDELC1/ EP58 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KDELC1/KDELC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1502-Ab-1/ GM-Tg-hg-SE1502-Ab-2Anti-Human KDELC1 monoclonal antibodyHuman
GM-Tg-rg-SE1502-Ab-1/ GM-Tg-rg-SE1502-Ab-2Anti-Rat KDELC1 monoclonal antibodyRat
GM-Tg-mg-SE1502-Ab-1/ GM-Tg-mg-SE1502-Ab-2Anti-Mouse KDELC1 monoclonal antibodyMouse
GM-Tg-cynog-SE1502-Ab-1/ GM-Tg-cynog-SE1502-Ab-2Anti-Cynomolgus/ Rhesus macaque KDELC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1502-Ab-1/ GM-Tg-felg-SE1502-Ab-2Anti-Feline KDELC1 monoclonal antibodyFeline
GM-Tg-cang-SE1502-Ab-1/ GM-Tg-cang-SE1502-Ab-2Anti-Canine KDELC1 monoclonal antibodyCanine
GM-Tg-bovg-SE1502-Ab-1/ GM-Tg-bovg-SE1502-Ab-2Anti-Bovine KDELC1 monoclonal antibodyBovine
GM-Tg-equg-SE1502-Ab-1/ GM-Tg-equg-SE1502-Ab-2Anti-Equine KDELC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1502-Ab-1/ GM-Tg-hg-SE1502-Ab-2; GM-Tg-rg-SE1502-Ab-1/ GM-Tg-rg-SE1502-Ab-2;
GM-Tg-mg-SE1502-Ab-1/ GM-Tg-mg-SE1502-Ab-2; GM-Tg-cynog-SE1502-Ab-1/ GM-Tg-cynog-SE1502-Ab-2;
GM-Tg-felg-SE1502-Ab-1/ GM-Tg-felg-SE1502-Ab-2; GM-Tg-cang-SE1502-Ab-1/ GM-Tg-cang-SE1502-Ab-2;
GM-Tg-bovg-SE1502-Ab-1/ GM-Tg-bovg-SE1502-Ab-2; GM-Tg-equg-SE1502-Ab-1/ GM-Tg-equg-SE1502-Ab-2
Products NameAnti-KDELC1 monoclonal antibody
Formatmab
Target NameKDELC1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KDELC1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1502-Ag-1Recombinant multi-species PLGT2/ KDELC1/ EP58 protein


    Target information

    Target IDGM-SE1502
    Target NameKDELC1
    Gene ID79070,72050,316370,702156,100855922,101082874,514810,100051191
    Gene Symbol and Synonyms1810049A15Rik,5730416C13Rik,EP58,ERp58,KDEL1,KDELC1,POGLUT2
    Uniprot AccessionQ6UW63
    Uniprot Entry NamePLGT2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134901
    Target ClassificationN/A

    The target: KDELC1, gene name: KDELC1, also named as EP58, ERp58, KDEL1. This gene encodes a protein product localized to the lumen of the endoplasmic reticulum. As a member of the endoplasmic reticulum protein family the encoded protein contains a Lys-Asp-Glu-Leu or KDEL motif located at the extreme C-terminus which prevents all endoplasmic reticulum resident proteins from being secreted. Proteins carrying this motif are bound by a receptor in the Golgi apparatus so that the receptor-ligand complex returns to the endoplasmic reticulum. A processed non-transcribed pseudogene located in an intron of a sodium transporter gene on chromosome 5 has been defined for this gene. This gene has multiple transcript variants which are predicted to encode distinct isoforms. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.